Effects of the non-steroidal anti-inflammatory drug celecoxib on cholesterol containing distearoyl phosphatidylcholine membranes

被引:5
|
作者
Sade, Asli [1 ]
Banerjee, Sreeparna [1 ]
Severcan, Feride [1 ]
机构
[1] Middle E Tech Univ, Dept Biol Sci, TR-06531 Ankara, Turkey
来源
SPECTROSCOPY-BIOMEDICAL APPLICATIONS | 2011年 / 25卷 / 3-4期
关键词
Celecoxib; cholesterol; DSPC; FTIR; MLV; LIPID ORGANIZATION; MODEL MEMBRANES; VITAMIN D-2; FLUIDITY; SPECTROSCOPY; INHIBITORS;
D O I
10.1155/2011/813853
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The effects of different concentrations of celecoxib on the acyl chain order, dynamics and the hydration status of the head group and interfacial region of model membranes containing DSPC and cholesterol were investigated in detail using Fourier transform infrared spectroscopy. Our results reveal that regardless of the presence of cholesterol, celecoxib is able to alter the physical properties of membranes. It exerts opposing effects on membrane order at high and low concentrations and decreases membrane fluidity in the presence of cholesterol. An evidence of phase separation has also been observed. The decrease in membrane fluidity supports the hypothesis that celecoxib may induce changes in the activity of membrane bound enzymes through modulating physical properties of the membrane thereby contributing to its anticancer activity. A possible change in the location of celecoxib in DSPC membranes when cholesterol is present has also been proposed. These results clarify, to a certain extent, the molecular interactions of celecoxib with membrane systems and may additionally contribute to a better understanding of COX-2 independent mechanisms of celecoxib action.
引用
收藏
页码:177 / 185
页数:9
相关论文
共 50 条
  • [1] Concentration-dependent differing actions of the nonsteroidal anti-inflammatory drug, celecoxib, in distearoyl phosphatidylcholine multilamellar vesicles
    Sade, Asli
    Banerjee, Sreeparna
    Severcan, Feride
    JOURNAL OF LIPOSOME RESEARCH, 2010, 20 (02) : 168 - 177
  • [2] Antimutagenic and anti-oxidant activities of the non-steroidal anti-inflammatory drug celecoxib
    Ajith, TA
    Subin, JP
    Jacob, J
    Sanjay, PS
    Babitha, NV
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2005, 32 (10) : 888 - 893
  • [3] Development of dual-release pellets of the non-steroidal anti-inflammatory drug celecoxib
    Hamed, Rania
    Omran, Haitham
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2020, 55
  • [4] Enamel biomineralization under the effects of indomethacin and celecoxib non-steroidal anti-inflammatory drugs
    Goncalves, Juliana de Lima
    Alves Duarte, Ana Caroline
    Almeida-Junior, Luciano Aparecido
    de Carvalho, Fabricio Kitazono
    de Queiroz, Alexandra Mussolino
    Manfrin Arnez, Maya Fernanda
    Faccioli, Lucia Helena
    Garcia Paula-Silva, Francisco Wanderley
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [5] Safety of non-steroidal anti-inflammatory drugs
    Weintraub, William S.
    EUROPEAN HEART JOURNAL, 2017, 38 (44) : 3293 - 3295
  • [6] Non-steroidal anti-inflammatory drugs and the heart
    Aneja, Ashish
    Farkouh, Michael E.
    HEART, 2011, 97 (07) : 517 - 518
  • [7] Celecoxib and other non-steroidal anti-inflammatory drugs in everyday clinical practice
    Brzezinska, Olga
    Makowska, Joanna
    ALERGIA ASTMA IMMUNOLOGIA, 2020, 25 (04): : 192 - 197
  • [8] Non-Steroidal Anti-Inflammatory Drug-Induced Enteropathy
    Lim, Yun Jeong
    Yang, Chang-Hun
    CLINICAL ENDOSCOPY, 2012, 45 (02) : 138 - 144
  • [9] Non-steroidal anti-inflammatory drugs and the gastrointestinal tract
    Tai, Foong Way David
    McAlindon, Mark E.
    CLINICAL MEDICINE, 2021, 21 (02) : 131 - 134
  • [10] Non-Steroidal Anti-Inflammatory Drug Induced Membrane Fusion: Concentration and Temperature Effects
    Mondal, Sutapa
    Sarkar, Munna
    JOURNAL OF PHYSICAL CHEMISTRY B, 2009, 113 (51) : 16323 - 16331